Motley Fool Wealth Management LLC Invests $9.07 Million in Alphatec Holdings, Inc. (NASDAQ:ATEC)

Key Points

• Motley Fool Wealth Management LLC has invested approximately $9.07 million in Alphatec Holdings, acquiring 894,471 shares, which represents 0.61% ownership of the company.
• Alphatec's stock recently reported earnings per share (EPS) of $0.02, surpassing analysts' expectations and showing a year-over-year revenue increase of 27.5%.
• A number of analysts have upgraded their ratings on Alphatec shares, with Barclays setting a new price target of $22.00, reflecting growing confidence in the company's performance.

Motley Fool Wealth Management LLC purchased a new position in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 894,471 shares of the medical technology company's stock, valued at approximately $9,070,000. Motley Fool Wealth Management LLC owned 0.61% of Alphatec as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in ATEC. Nuveen LLC acquired a new position in shares of Alphatec during the first quarter worth about $135,874,000. Royal Bank of Canada boosted its holdings in Alphatec by 171.2% during the fourth quarter. Royal Bank of Canada now owns 3,185,283 shares of the medical technology company's stock worth $29,240,000 after buying an additional 2,010,806 shares in the last quarter. Nuveen Asset Management LLC boosted its holdings in Alphatec by 78.4% during the fourth quarter. Nuveen Asset Management LLC now owns 2,584,996 shares of the medical technology company's stock worth $23,730,000 after buying an additional 1,136,330 shares in the last quarter. Marshall Wace LLP boosted its holdings in Alphatec by 139.2% during the fourth quarter. Marshall Wace LLP now owns 1,773,246 shares of the medical technology company's stock worth $16,278,000 after buying an additional 1,032,070 shares in the last quarter. Finally, Western Standard LLC purchased a new stake in Alphatec during the fourth quarter worth about $6,668,000. 66.35% of the stock is currently owned by institutional investors and hedge funds.

Alphatec Stock Up 0.5%

Shares of NASDAQ ATEC opened at $14.97 on Monday. Alphatec Holdings, Inc. has a 12-month low of $4.88 and a 12-month high of $15.46. The company has a market capitalization of $2.22 billion, a PE ratio of -13.25 and a beta of 1.05. The company has a debt-to-equity ratio of 23.22, a current ratio of 2.88 and a quick ratio of 1.77. The firm's 50-day moving average is $11.63 and its two-hundred day moving average is $11.28.

Alphatec (NASDAQ:ATEC - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The medical technology company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.08. Alphatec had a negative net margin of 24.33% and a negative return on equity of 1,657.19%. The company had revenue of $185.54 million for the quarter, compared to the consensus estimate of $178.85 million. During the same quarter in the prior year, the firm earned ($0.29) earnings per share. The company's revenue for the quarter was up 27.5% compared to the same quarter last year. Equities analysts anticipate that Alphatec Holdings, Inc. will post -1.08 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts recently commented on ATEC shares. Barclays reissued an "overweight" rating and set a $22.00 price objective (up previously from $21.00) on shares of Alphatec in a report on Monday, August 4th. Piper Sandler reissued an "overweight" rating and set a $15.00 price objective (up previously from $13.00) on shares of Alphatec in a report on Friday, May 2nd. Canaccord Genuity Group reissued a "buy" rating and set a $20.00 price objective on shares of Alphatec in a report on Friday, August 1st. Lake Street Capital raised shares of Alphatec to a "buy" rating and set a $18.00 price objective on the stock in a report on Monday, June 16th. Finally, Wall Street Zen raised shares of Alphatec from a "hold" rating to a "buy" rating in a report on Saturday. Seven investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Alphatec currently has an average rating of "Buy" and a consensus target price of $18.50.

Insider Buying and Selling at Alphatec

In other news, EVP Craig E. Hunsaker sold 10,876 shares of the business's stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $15.33, for a total value of $166,729.08. Following the completion of the transaction, the executive vice president owned 1,389,142 shares of the company's stock, valued at $21,295,546.86. The trade was a 0.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, General Counsel Tyson Eliot Marshall sold 18,092 shares of the business's stock in a transaction that occurred on Tuesday, August 5th. The shares were sold at an average price of $14.91, for a total transaction of $269,751.72. Following the completion of the transaction, the general counsel directly owned 438,331 shares of the company's stock, valued at approximately $6,535,515.21. This represents a 3.96% decrease in their position. The disclosure for this sale can be found here. Insiders sold 449,997 shares of company stock worth $5,846,616 over the last ninety days. 20.90% of the stock is currently owned by company insiders.

About Alphatec

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.

Want to see what other hedge funds are holding ATEC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alphatec Holdings, Inc. (NASDAQ:ATEC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.